B. Gami, K. Harrington, P. Blake, D. Dearnaley, D. Tait et al., How patients manage gastrointestinal symptoms after pelvic radiotherapy, Alimentary Pharmacology and Therapeutics, vol.12, issue.5, pp.987-994, 2003.
DOI : 10.1016/0360-3016(86)90037-4

D. Kuban, S. Tucker, L. Dong, G. Starkschall, E. Huang et al., Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.70, issue.1, pp.67-74, 2008.
DOI : 10.1016/j.ijrobp.2007.06.054

J. Cox, J. Stetz, and T. Pajak, Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC), International Journal of Radiation Oncology*Biology*Physics, vol.31, issue.5, pp.1341-13460360, 1995.
DOI : 10.1016/0360-3016(95)00060-C

D. N. , N. , and D. , In: Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0 [Internet], 2006.

P. Rubin, L. Constine, L. Fajardo, T. Phillips, and T. Wasserman, Overview: Late effects of normal tissues (LENT) scoring system, International Journal of Radiation Oncology*Biology*Physics, vol.31, issue.5, pp.1041-1042, 1995.
DOI : 10.1016/0360-3016(95)00057-6

S. Pergolizzi, E. Maranzano, D. Angelis, V. Lupattelli, M. Frata et al., Diarrhoea in irradiated patients: A prospective multicentre observational study, Digestive and Liver Disease, vol.45, issue.11, pp.933-937, 2013.
DOI : 10.1016/j.dld.2013.04.012

C. Fiorino, T. Rancati, G. Fellin, V. Vavassori, E. Cagna et al., Late Fecal Incontinence After High-Dose Radiotherapy for Prostate Cancer: Better Prediction Using Longitudinal Definitions, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.1, pp.38-45, 2012.
DOI : 10.1016/j.ijrobp.2011.06.1953

R. Valdagni, M. Kattan, T. Rancati, C. Yu, V. Vavassori et al., Is It Time to Tailor the Prediction of Radio-Induced Toxicity in Prostate Cancer Patients? Building the First Set of Nomograms for Late Rectal Syndrome, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.5, pp.1957-1966, 2012.
DOI : 10.1016/j.ijrobp.2011.03.028

G. Viani, E. Stefano, and S. Afonso, Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-analysis of Randomized, Controlled Trials, International Journal of Radiation Oncology*Biology*Physics, vol.74, issue.5, pp.1405-1418, 2009.
DOI : 10.1016/j.ijrobp.2008.10.091

S. Wachter, N. Gerstner, G. Goldner, R. Pötzi, A. Wambersie et al., Endoscopic scoring of late rectal mucosal damage after conformal radiotherapy for prostatic carcinoma, Radiotherapy and Oncology, vol.54, issue.1, pp.11-19, 2000.
DOI : 10.1016/S0167-8140(99)00173-5

M. Stenmark, A. Conlon, S. Johnson, S. Daignault, D. Litzenberg et al., Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancer, Radiotherapy and Oncology, vol.110, issue.2, pp.291-297, 2014.
DOI : 10.1016/j.radonc.2014.01.007

G. Dréan, O. Acosta, J. Ospina, A. Fargeas, C. Lafond et al., Identification of a rectal subregion highly predictive of rectal bleeding in prostate cancer IMRT, Radiotherapy and Oncology, vol.119, issue.3, 2016.
DOI : 10.1016/j.radonc.2016.04.023

K. Hoffman, K. Voong, T. Pugh, H. Skinner, L. Levy et al., Risk of Late Toxicity in Men Receiving Dose-Escalated Hypofractionated Intensity Modulated Prostate Radiation Therapy: Results From a Randomized Trial, International Journal of Radiation Oncology*Biology*Physics, vol.88, issue.5, pp.1074-1084, 2014.
DOI : 10.1016/j.ijrobp.2014.01.015

S. Aluwini, F. Pos, E. Schimmel, S. Krol, P. Van-der-toorn et al., Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial, The Lancet Oncology, vol.17, issue.4, pp.464-474, 2016.
DOI : 10.1016/S1470-2045(15)00567-7

M. Zelefsky, M. Kollmeier, B. Cox, A. Fidaleo, D. Sperling et al., Improved Clinical Outcomes With High-Dose Image Guided Radiotherapy Compared With Non-IGRT for the Treatment of Clinically Localized Prostate Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.84, issue.1, pp.125-129, 2012.
DOI : 10.1016/j.ijrobp.2011.11.047

M. Valeriani, S. Bracci, M. Osti, T. Falco, L. Agolli et al., Intermediate-risk prostate cancer patients treated with androgen deprivation therapy and a hypofractionated radiation regimen with or without image guided radiotherapy, Radiation Oncology, vol.8, issue.1, pp.137-23759081, 2013.
DOI : 10.1016/S1470-2045(12)70084-0

D. Kok, S. Gill, M. Bressel, K. Byrne, T. Kron et al., Late toxicity and biochemical control in 554 prostate cancer patients treated with and without dose escalated image guided radiotherapy, Radiotherapy and Oncology, vol.107, issue.2, pp.140-146, 2013.
DOI : 10.1016/j.radonc.2013.04.007

J. Sveistrup, J. Deasy, J. Oh, T. Pommer, and P. Petersen, Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance, Radiation Oncology, vol.9, issue.1, pp.44-24495815, 2014.
DOI : 10.1111/j.1442-2042.2012.03052.x

R. Wortel, L. Incrocci, F. Pos, J. Lebesque, M. Witte et al., Acute Toxicity After Image-Guided Intensity Modulated Radiation Therapy Compared to 3D Conformal Radiation Therapy in Prostate Cancer Patients, International Journal of Radiation Oncology*Biology*Physics, vol.91, issue.4, pp.737-744, 2015.
DOI : 10.1016/j.ijrobp.2014.12.017

J. Ospina, J. Zhu, C. Chira, A. Bossi, J. Delobel et al., Random Forests to Predict Rectal Toxicity Following Prostate Cancer Radiation Therapy, International Journal of Radiation Oncology*Biology*Physics, vol.89, issue.5, pp.1024-1031, 2014.
DOI : 10.1016/j.ijrobp.2014.04.027

V. Landoni, C. Fiorino, C. Cozzarini, G. Sanguineti, R. Valdagni et al., Predicting toxicity in radiotherapy for prostate cancer, Physica Medica, vol.32, issue.3, pp.521-532, 2016.
DOI : 10.1016/j.ejmp.2016.03.003

E. Varela, M. Antolín, F. Guarner, R. Verges, J. Giralt et al., Faecal DNA and calprotectin as biomarkers of acute intestinal toxicity in patients undergoing pelvic radiotherapy, Alimentary Pharmacology & Therapeutics, vol.42, issue.2, pp.175-185, 2009.
DOI : 10.1080/02841860310011302

L. Wedlake, C. Mcgough, C. Hackett, K. Thomas, P. Blake et al., Can biological markers act as non-invasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa?, Alimentary Pharmacology & Therapeutics, vol.46, issue.10, pp.980-987, 2008.
DOI : 10.1016/S0360-3016(03)00781-8

R. Burri, R. Stock, J. Cesaretti, D. Atencio, S. Peters et al., with Susceptibility for the Development of Adverse Effects Resulting from Radiotherapy for Prostate Cancer, Radiation Research, vol.170, issue.1, pp.49-59, 2008.
DOI : 10.1667/RR1219.1

J. Coates, A. Jeyaseelan, N. Ybarra, M. David, S. Faria et al., Contrasting analytical and data-driven frameworks for radiogenomic modeling of normal tissue toxicities in prostate cancer, Radiotherapy and Oncology, vol.115, issue.1, pp.107-113, 2015.
DOI : 10.1016/j.radonc.2015.03.005

S. Damaraju, D. Murray, J. Dufour, D. Carandang, S. Myrehaug et al., Association of DNA Repair and Steroid Metabolism Gene Polymorphisms with Clinical Late Toxicity in Patients Treated with Conformal Radiotherapy for Prostate Cancer, Clinical Cancer Research, vol.12, issue.8, pp.2545-2554, 2006.
DOI : 10.1158/1078-0432.CCR-05-2703

E. Thurner, S. Krenn-pilko, U. Langsenlehner, W. Renner, A. Gerger et al., Zusammenhang zwischen Polymorphismen in den Apoptosegenen FAS und FASL mit strahleninduzierter Sp??ttoxizit??t nach Radiotherapie des Prostatakarzinoms, Strahlentherapie und Onkologie, vol.8, issue.3, pp.304-309, 2014.
DOI : 10.2741/927

R. Valdagni, T. Rancati, M. Ghilotti, C. Cozzarini, V. Vavassori et al., To Bleed or Not to Bleed. A Prediction Based on Individual Gene Profiling Combined With Dose???Volume Histogram Shapes in Prostate Cancer Patients Undergoing Three-Dimensional Conformal Radiation Therapy, International Journal of Radiation Oncology*Biology*Physics, vol.74, issue.5, pp.1431-1440, 2009.
DOI : 10.1016/j.ijrobp.2008.10.021

M. Someya, H. Yamamoto, M. Nojima, M. Hori, K. Tateoka et al., Relation between Ku80 and microRNA-99a expression and late rectal bleeding after radiotherapy for prostate cancer, Radiotherapy and Oncology, vol.115, issue.2, pp.235-239, 2015.
DOI : 10.1016/j.radonc.2015.04.008